Hot Keywords
Metabolism Target Organ Damage Diabetes Obesity Metabolic Syndrome Metabolic Disease Cardiovascular Disease Metabolomics Liver NAFLD MAFLD Kidney

Topic: Mechanosignaling Pathways in Metabolic Dysfunction

Submission deadline: 31 Jan 2022

Guest Editor(s)

  • Gyorgy Baffy, MD, PhD
    Department of Medicine, VA Boston Healthcare System and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

    Website | E-mail

Special Issue Introduction

The biological functions of living cells and tissues are greatly affected by their physical microenvironment. There is a growing appreciation of the precise molecular and cellular mechanisms by which cells are able to detect, transmit and translate mechanical signals into biochemical responses. This process has been termed mechanotransduction, encompassing physical forces (e.g., compression, stretch, and shear) acting on cell surface mechanosensors (e.g., ion channels, transmembrane receptors, and adhesion molecules) that link mechanical impact to cytoskeleton structures (e.g., microtubules, actin, and intermediate filaments), and it may activate intracellular signaling cascades and yield pleiotropic mediators (e.g., nitric oxide, calcium, and reactive oxygen species) or engage developmental pathways (e.g., Wnt/beta-catenin, Hippo/YAP/TAZ, and Hedgehog) with complex genetic programs and cellular outcomes.

There is increasing evidence for the specific role of mechanotransduction in the pathogenesis of nonalcoholic fatty liver disease associated with metabolic dysfunction (NAFLD/MAFLD). Liver sinusoids represent a unique environment in which parenchymal hepatocytes, liver endothelial cells, hepatic stellate cells, and Kupffer cells have incredibly complex interactions as they are affected by the aberrant accumulation of lipid droplets, stiff extracellular matrix and liver fibrosis, and altered blood flow and pressure. Current research has begun to identify some of the key mechanosignaling pathways associated with the changing physical environment in NAFLD/MAFLD that could increasingly disrupt sinusoidal homeostasis and contribute to disease progression. These molecular mechanisms are associated with liver cell injury, inflammation, fibrosis, portal hypertension, and hepatocarcinogenesis, while it is expected that they will also provide novel targets for therapeutic interventions. It is our intention to make this special issue an important milestone in achieving this goal.

We welcome original or review manuscripts, perspectives, opinions, and commentary on different aspects to this special issue, including but not limited to:

Hepatic mechanosensors of lipid accumulation
Mechanotransduction and insulin resistance in fatty liver disease
Mechanosensitive pathways in sinusoidal endothelial dysfunction
Mechano-stress and the liver inflammatory response
Obesity, myosteatosis, and mechanotransduction
Mechanosignaling aspects of portal hypertension
Mechanotransduction and hepatocarcinogenesis
Gut microbiota and liver mechanosignaling
Liver genetic programs activated by mechanotransduction


1. Moira Hilscher Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
2. Loretta L. Jophlin  Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
The list is arranged in no particular order and being updated.

Submission Deadline

31 Jan 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 31 Jan 2022
Contacts: Doreen Deng, Managing Editor,
                  Zoe Zhang, Assistant Editor,

Published Articles

This special issue is now open for submission.
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties